<unk>  is contraindicated in patients with known hypersensitivity to<unk> , peanut or soya.<unk>  has not been tested in patients with moderate to severe impairment of liver function. Given that the drug is metabolised in the liver, it may not be safe in such patients.<unk>  can be used in geriatric population without any dose modifications. It has not been studied in paediatric populations and hence cannot be given in patients below 18 years of age. It is also contraindicated in pregnancy
Nintedanib
Vatalanib
Gilteritinib
Abrocitinib
Pegaptanib
Tivozanib
Alectinib
Sunitinib